Literature DB >> 15620407

Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology.

Takeshi Sakurai1.   

Abstract

Orexins, which were initially identified as endogenous peptide ligands for two orphan G-protein coupled receptors (GPCRs), have been shown to have an important role in the regulation of energy homeostasis. Furthermore, the discovery of orexin deficiency in narcolepsy patients indicated that orexins are highly important factors for the sleep/wakefulness regulation. The efferent and afferent systems of orexin-producing neurons suggest interactions between these cells and arousal centers in the brainstem as well as important feeding centers in the hypothalamus. Electrophysiological studies have shown that orexin neurons are regulated by humoral factors, including leptin, glucose, and ghrelin as well as monoamines and acetylcholin. Thus, orexin neurons have functional interactions with hypothalamic feeding pathways and monoaminergic/cholinergic centers to provide a link between peripheral energy balance and the CNS mechanisms that coordinate sleep/wakefulness states and motivated behavior such as food seeking.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15620407     DOI: 10.1016/j.regpep.2004.08.006

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  10 in total

1.  Ligand-induced internalization of the orexin OX(1) and cannabinoid CB(1) receptors assessed via N-terminal SNAP and CLIP-tagging.

Authors:  Richard J Ward; John D Pediani; Graeme Milligan
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 2.  Energy expenditure: role of orexin.

Authors:  Jennifer A Teske; Vijayakumar Mavanji
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

3.  Selective loss of GABA(B) receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture.

Authors:  Taizo Matsuki; Mika Nomiyama; Hitomi Takahira; Noriko Hirashima; Satoshi Kunita; Satoru Takahashi; Ken-ichi Yagami; Thomas S Kilduff; Bernhard Bettler; Masashi Yanagisawa; Takeshi Sakurai
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

Review 4.  Brain circuits regulating energy homeostasis.

Authors:  Alfonso Abizaid; Tamas L Horvath
Journal:  Regul Pept       Date:  2008-03-25

5.  Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression.

Authors:  Clarissa D Staton; Jazmine D W Yaeger; Delan Khalid; Fadi Haroun; Belissa S Fernandez; Jessica S Fernandez; Bali K Summers; Tangi R Summers; Monica Sathyanesan; Samuel S Newton; Cliff H Summers
Journal:  Neuropharmacology       Date:  2018-09-18       Impact factor: 5.250

6.  Early improvement in obstructive sleep apnea and increase in orexin levels after bariatric surgery in adolescents and young adults.

Authors:  Raouf Amin; Narong Simakajornboon; Rhonda Szczesniak; Thomas Inge
Journal:  Surg Obes Relat Dis       Date:  2016-05-30       Impact factor: 4.734

7.  Role of orexin in modulating arousal, feeding, and motivation.

Authors:  Natsuko Tsujino; Takeshi Sakurai
Journal:  Front Behav Neurosci       Date:  2013-04-18       Impact factor: 3.558

8.  Neural circuit interactions between the dorsal raphe nucleus and the lateral hypothalamus: an experimental and computational study.

Authors:  Jaishree Jalewa; Alok Joshi; T Martin McGinnity; Girijesh Prasad; KongFatt Wong-Lin; Christian Hölscher
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

9.  Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora.

Authors:  Sergueï O Fetissov; Maria Hamze Sinno; Moïse Coëffier; Christine Bole-Feysot; Philippe Ducrotté; Tomas Hökfelt; Pierre Déchelotte
Journal:  Nutrition       Date:  2008-02-08       Impact factor: 4.008

Review 10.  New Insights on Metabolic and Genetic Basis of Migraine: Novel Impact on Management and Therapeutical Approach.

Authors:  Irene Simonetta; Renata Riolo; Federica Todaro; Antonino Tuttolomondo
Journal:  Int J Mol Sci       Date:  2022-03-11       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.